This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various therapeutic agents. Its unique spirocyclic structure makes it valuable in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. Additionally, it serves as a key building block in the creation of compounds with potential anti-inflammatory and analgesic properties, contributing to the formulation of medications aimed at managing pain and inflammation. Its application extends to research settings, where it is used to study the structure-activity relationships of spirocyclic compounds, aiding in the discovery of new drug candidates with improved efficacy and safety profiles.